The global T-Cell therapy market size in 2023 is 3055.0 million US dollars, and it is expected to be 9446.6 million US dollars by 2030, with a compound annual growth rate of 17.5% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the T-Cell therapy market include Merck KGaA, Johnson & Johnson, AbbVie, Inc., Gilead Sciences, Inc., and Amgen, Inc.. The share of the top 3 players in the T-Cell therapy market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of T-Cell therapy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. CAR T-Cell Therapy accounted for XX% of T-Cell therapy market in 2023. T-Cell Receptor (TCR)-Based share of XX%.
Hospitals accounted for XX% of the T-Cell therapy market in 2023. Cancer Treatment Centers accounts for XX%.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global T-Cell therapy Market dynamics, structure by identifying and analyzing the market segments and project the global market size.

In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.

Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
 
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, application, and regional division, and then includes inflation analysis, and the impact of the Russo-Ukrainian war on the market.
Chapter 2: Analysis of the competitive environment of T-Cell therapy market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapter 3: Analyzes the main companies in the T-Cell therapy industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 4-6: Segmented the global T-Cell therapy market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-15: Provide North America, Europe, China, Japan, Korea, Southeast Asia, India, South America and Middle East & Africa T-Cell therapy market region data and PEST analysis.
Chapter 16: Analyzes the T-Cell therapy business cost, including industrial chain and the proportion of business cost structure.
Chapter 17: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapter 18: The main points and conclusions of the report.

Highlights-Regions
North America
Europe
China
Japan
Korea
Southeast Asia
India
South America
Middle East & Africa

Player list
Merck KGaA
Johnson & Johnson
AbbVie, Inc.
Gilead Sciences, Inc.
Amgen, Inc.
Novartis AG
Sorrento Therapeutics, Inc.
Bristol Myers Squibb Company
Immunocore Holdings plc
Pfizer, Inc.

Types list
CAR T-Cell Therapy
T-Cell Receptor (TCR)-Based

Application list
Hospitals
Cancer Treatment Centers

Table of Content

1 T-Cell therapy Market Introduction and Overview
1.1 T-Cell therapy Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global T-Cell therapy Revenue and Market Share by Manufacturer
2.2 Manufacturers T-Cell therapy Area Served, Product Types
2.3 T-Cell therapy Market Competitive Situation and Trends
2.3.1 T-Cell therapy Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Merck KGaA
3.1.1 Merck KGaA Company Profile
3.1.2 T-Cell therapy Product Overview
3.1.3 Merck KGaA T-Cell therapy Market Performance (2019-2024)
3.1.4 Merck KGaA Business Overview
3.2 Johnson & Johnson
3.2.1 Johnson & Johnson Company Profile
3.2.2 T-Cell therapy Product Overview
3.2.3 Johnson & Johnson T-Cell therapy Market Performance (2019-2024)
3.2.4 Johnson & Johnson Business Overview
3.3 AbbVie, Inc.
3.3.1 AbbVie, Inc. Company Profile
3.3.2 T-Cell therapy Product Overview
3.3.3 AbbVie, Inc. T-Cell therapy Market Performance (2019-2024)
3.3.4 AbbVie, Inc. Business Overview
3.4 Gilead Sciences, Inc.
3.4.1 Gilead Sciences, Inc. Company Profile
3.4.2 T-Cell therapy Product Overview
3.4.3 Gilead Sciences, Inc. T-Cell therapy Market Performance (2019-2024)
3.4.4 Gilead Sciences, Inc. Business Overview
3.5 Amgen, Inc.
3.5.1 Amgen, Inc. Company Profile
3.5.2 T-Cell therapy Product Overview
3.5.3 Amgen, Inc. T-Cell therapy Market Performance (2019-2024)
3.5.4 Amgen, Inc. Business Overview
3.6 Novartis AG
3.6.1 Novartis AG Company Profile
3.6.2 T-Cell therapy Product Overview
3.6.3 Novartis AG T-Cell therapy Market Performance (2019-2024)
3.6.4 Novartis AG Business Overview
3.7 Sorrento Therapeutics, Inc.
3.7.1 Sorrento Therapeutics, Inc. Company Profile
3.7.2 T-Cell therapy Product Overview
3.7.3 Sorrento Therapeutics, Inc. T-Cell therapy Market Performance (2019-2024)
3.7.4 Sorrento Therapeutics, Inc. Business Overview
3.8 Bristol Myers Squibb Company
3.8.1 Bristol Myers Squibb Company Company Profile
3.8.2 T-Cell therapy Product Overview
3.8.3 Bristol Myers Squibb Company T-Cell therapy Market Performance (2019-2024)
3.8.4 Bristol Myers Squibb Company Business Overview
3.9 Immunocore Holdings plc
3.9.1 Immunocore Holdings plc Company Profile
3.9.2 T-Cell therapy Product Overview
3.9.3 Immunocore Holdings plc T-Cell therapy Market Performance (2019-2024)
3.9.4 Immunocore Holdings plc Business Overview
3.10 Pfizer, Inc.
3.10.1 Pfizer, Inc. Company Profile
3.10.2 T-Cell therapy Product Overview
3.10.3 Pfizer, Inc. T-Cell therapy Market Performance (2019-2024)
3.10.4 Pfizer, Inc. Business Overview
4 Global T-Cell therapy Historical and Forecast Market Analysis by Type
4.1 Global T-Cell therapy Revenue and Market Share by Type
4.2 Global T-Cell therapy Revenue Market Forecast by Type (2024-2030)
5 Global T-Cell therapy Historical and Forecast Market Analysis by Application
5.1 Global T-Cell therapy Revenue Market Share by Application (2019-2024)
5.2 T-Cell therapy Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global T-Cell therapy Market Size & Forecast (2019-2030)
6.2 T-Cell therapy Growth Trends Analysis by Regions
6.2.1 T-Cell therapy Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 T-Cell therapy Historic Revenue Market Size by Regions (2019-2024)
6.2.3 T-Cell therapy Forecasted Revenue Market Size by Regions (2024-2030)
7 North America
7.1 North America T-Cell therapy Revenue Market Size & Forecast (2019-2030)
7.2 North America T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
7.3 North America PEST Analysis
8 Europe
8.1 Europe T-Cell therapy Revenue Market Size & Forecast (2019-2030)
8.2 Europe T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
8.3 Europe PEST Analysis
9 China
9.1 China T-Cell therapy Revenue Market Size & Forecast (2019-2030)
9.2 China T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
9.3 China PEST Analysis
10 Japan
10.1 Japan T-Cell therapy Revenue Market Size & Forecast (2019-2030)
10.2 Japan T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
10.3 Japan PEST Analysis
11 Korea
11.1 Korea T-Cell therapy Revenue Market Size & Forecast (2019-2030)
11.2 Korea T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
11.3 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia T-Cell therapy Revenue Market Size & Forecast (2019-2030)
12.2 Southeast Asia T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
12.3 Southeast Asia PEST Analysis
13 India
13.1 India T-Cell therapy Revenue Market Size & Forecast (2019-2030)
13.2 India T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
13.3 India PEST Analysis
14 South America
14.1 South America T-Cell therapy Revenue Market Size & Forecast (2019-2030)
14.2 South America T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
14.3 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa T-Cell therapy Revenue Market Size & Forecast (2019-2030)
15.2 Middle East & Africa T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
15.3 Middle East & Africa PEST Analysis
16 T-Cell therapy Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 T-Cell therapy Industrial Chain Analysis
17 T-Cell therapy Industry Dynamic Analysis
17.1 T-Cell therapy Market Trends Analysis
17.2 T-Cell therapy Market Drivers Analysis
17.3 T-Cell therapy Market Challenges Analysis
17.4 T-Cell therapy Market Restraints Analysis

List of Tables and Figures

Figure T-Cell therapy Picture
Table Product Definition of T-Cell therapy
Table Global T-Cell therapy Market Size by Type (2024 VS 2030)
Figure Global T-Cell therapy Market Share by Type 2024 VS 2030
Table Global T-Cell therapy Market Size by Application (2024 VS 2030)
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global T-Cell therapy Revenue ($) by Manufacturer (2019-2024)
Table Global T-Cell therapy Revenue Market Share by Manufacturer (2019-2024)
Figure Global T-Cell therapy Revenue Market Share by Manufacturer in 2024
Table Manufacturers T-Cell therapy Area Served, Product Types
Table T-Cell therapy Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2024
Table Mergers & Acquisitions, Expansion Plans
Table Merck KGaA Profile
Table Product Overview
Table Merck KGaA T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Merck KGaA Revenue and Growth Rate
Figure Merck KGaA Revenue Market Share 2019-2024
Table Business Overview
Table Johnson & Johnson Profile
Table Product Overview
Table Johnson & Johnson T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Johnson & Johnson Revenue and Growth Rate
Figure Johnson & Johnson Revenue Market Share 2019-2024
Table Business Overview
Table AbbVie, Inc. Profile
Table Product Overview
Table AbbVie, Inc. T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure AbbVie, Inc. Revenue and Growth Rate
Figure AbbVie, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Gilead Sciences, Inc. Profile
Table Product Overview
Table Gilead Sciences, Inc. T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Gilead Sciences, Inc. Revenue and Growth Rate
Figure Gilead Sciences, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Amgen, Inc. Profile
Table Product Overview
Table Amgen, Inc. T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Amgen, Inc. Revenue and Growth Rate
Figure Amgen, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Novartis AG Profile
Table Product Overview
Table Novartis AG T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Novartis AG Revenue and Growth Rate
Figure Novartis AG Revenue Market Share 2019-2024
Table Business Overview
Table Sorrento Therapeutics, Inc. Profile
Table Product Overview
Table Sorrento Therapeutics, Inc. T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Sorrento Therapeutics, Inc. Revenue and Growth Rate
Figure Sorrento Therapeutics, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Bristol Myers Squibb Company Profile
Table Product Overview
Table Bristol Myers Squibb Company T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Bristol Myers Squibb Company Revenue and Growth Rate
Figure Bristol Myers Squibb Company Revenue Market Share 2019-2024
Table Business Overview
Table Immunocore Holdings plc Profile
Table Product Overview
Table Immunocore Holdings plc T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Immunocore Holdings plc Revenue and Growth Rate
Figure Immunocore Holdings plc Revenue Market Share 2019-2024
Table Business Overview
Table Pfizer, Inc. Profile
Table Product Overview
Table Pfizer, Inc. T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Pfizer, Inc. Revenue and Growth Rate
Figure Pfizer, Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Global T-Cell therapy Revenue and Market Size by Type (2019-2024)
Table Global T-Cell therapy Revenue and Market Share by Type (2019-2024)
Table Global T-Cell therapy Revenue Market Size Forecast by Type (2024-2030)
Table Global T-Cell therapy Revenue Market Share Forecast by Type (2024-2030)
Table Global T-Cell therapy Revenue Market Size by Application (2019-2024)
Table Global T-Cell therapy Revenue Market Share by Application (2019-2024)
Table Global T-Cell therapy Revenue Market Size by Application (2024-2030)
Table Global T-Cell therapy Revenue Market Share by Application (2024-2030)
Figure Global T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table T-Cell therapy Market Size by Regions: 2019 VS 2024 VS 2030
Table T-Cell therapy Historic Revenue Market Size by Regions (2019-2024)
Table T-Cell therapy Historic Revenue Market Share by Regions (2019-2024)
Table T-Cell therapy Forecasted Revenue Market Size by Regions (2024-2030)
Table T-Cell therapy Forecasted Revenue Market Share by Regions (2024-2030)
Figure North America T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table North America T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table North America PEST Analysis
Figure Europe T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table Europe T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table Europe PEST Analysis
Figure China T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table China T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table China PEST Analysis
Figure Japan T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table Japan T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table Japan PEST Analysis
Figure Korea T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table Korea T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table Korea PEST Analysis
Figure Southeast Asia T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table Southeast Asia T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table Southeast Asia PEST Analysis
Figure India T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table India T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table India PEST Analysis
Figure South America T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table South America T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table South America PEST Analysis
Figure Middle East & Africa T-Cell therapy Revenue Market Size & Forecast (2019-2030)
Table Middle East & Africa T-Cell therapy Revenue, Gross and Gross Margin (2019-2024)
Table Middle East & Africa PEST Analysis
Figure Proportion of Business Cost Structure
Table Labor Cost Analysis
Table Operating Expenses Analysis
Figure T-Cell therapy Industrial Chain Analysis
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis